论文部分内容阅读
[目的]观察补肾健脾方治疗原发性肝癌的临床疗效。[方法]将45例随机分成两组。对照组给予保肝及对症治疗,治疗组给予保肝及对症治疗,在对照组基础上,另予补肾健脾方。[结果]治疗组总有效率86.95%,对照组总有效率54.54%,两组比较差异有显著性(P<0.05)。[结论]补肾健脾方治疗原发性肝癌,疗效显著,安全可靠。
[Objective] To observe the clinical efficacy of Bushen Jianpi Fang in treating primary liver cancer. [Methods] 45 cases were randomly divided into two groups. The control group was given hepatoprotective and symptomatic treatment, and the treatment group was given hepatoprotective and symptomatic treatment. On the basis of the control group, another prescription was given to supplement kidney and invigorate the spleen. [Results] The total effective rate was 86.95% in the treatment group and 54.54% in the control group. There was significant difference between the two groups (P <0.05). [Conclusion] Bushen Jianpi Fang in the treatment of primary liver cancer has significant curative effect and is safe and reliable.